Nihon Kohden, a global leader in neurodiagnostic, patient, monitoring and ventilation, today announced it is expanding the ...
Phase 1 Part 3 Trial of DA-1726 to Initiate in April 2026 On March 18, 2026, MetaVia, Inc. (NASDAQ: MTVA) announced the approval of the clinical trial plan by the Institutional Review Board (IRB) at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results